Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.

Cardiovasc Diabetol · 2017 · PMC5391604 · PMID 28410617

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

As a result, F1.2 levels were lower in the n-3 PUFA group (p = 0.04) at the end of the study, but the differences were of borderline significance (Table 2 ; Fig. 2 ).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.